[PDF] Top 20 Novel agents for anti-platelet therapy
Has 10000 "Novel agents for anti-platelet therapy" found on our website. Below are the top 20 most common "Novel agents for anti-platelet therapy".
Novel agents for anti-platelet therapy
... initial platelet binding event stimulates platelet activation, recruitment, and activation of the clotting cascade, thereby promoting thrombus ...humanized anti-vWF-A1 chimeric Fab antibody that can ... See full document
7
Nanobodies as novel agents for disease diagnosis and therapy
... therapeutic agents that inhibit targets involved in disease progression, or by causing the cytotoxic death of target cells, which are mediated by modulators of the immune response; alternatively, Abs can act as ... See full document
13
Dendrimers as a Novel Carrier in Anti-HIV Therapy
... Dendrimers are macromolecules with a defined globular shape that were synthesized for the first time at the end of the 1970s. They are sophisticated and curious molecules and have attracted the interest of chemists owing ... See full document
6
Mitocans as Novel Agents for Anticancer Therapy: An Overview
... are novel targets showing considerable prom- ise for intervention and treatment of cancer ...[3-5]. Anti- cancer agents specifically targeting cancer cell mito- chondria are referred to as ... See full document
15
A STUDY ON RISK OF PRE-EXISTING ANTIPLATELET THERAPY IN INTRACRANIAL HEMORRHAGE AND ASSESSING IMPACT OF PATIENT COUNSELLING IN HEALTH RELATED QUALITY OF LIFE
... pre-existing anti-platelet therapy in causing and worsening of intracranial hemorrhagic patients and to assess the impact of patient counselling in improving their health related quality of life with ... See full document
12
Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies
... to anti-platelet treatments are still the most cost-effective treatment strategies [17, ...of platelet accumulation has been critical for further developing novel antiplatelet therapies, such ... See full document
10
A Cross-Sectional Study to Evaluate Age and Gender Related Differences in Drug Utilization in Ischemic Heart Disease at A Tertiary Care Hospital
... 0.0033). Anti-platelet drugs (100%) followed by Lipid lowering drugs (96%) were most commonly ...Dual anti-platelet therapy was found to be significant among men ...inhibitors, ... See full document
8
Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study
... that anti-platelet agents may increase the primary pat- ency of AVF, the limited evidence base and the uncertainty regarding the choice of agent has not supported the wide- spread use of ... See full document
12
Comparison of Mean Platelet Volume in Type 2 Diabetics on Insulin Therapy and Oral Hypoglycaemic Agents
... Increased platelet reactivity and insulin resistance are considered to be the prime determinants of all the vascular complications in ...antiplatelet therapy in the diabetic population in comparison to ... See full document
134
Click here to download PDF version of the article !
... of platelet aggregation [6]. Hence, monitoring of anti-platelet therapy is essential due to variability in anti-platelet response seen with aspirin and ADP receptor ...ideal ... See full document
5
NATURAL ANTI-PLATELET AGENTS
... Antiplatelet agents are useful as antithrombotic ...for anti-platelet ...the anti-platelet effect of: double blind randomized versus placebo clinical assay of Policosanol (1 mg/day x 12 ... See full document
8
ANALYSIS OF NOVEL MTA NUCLEOSIDASE INHIBITORS AS ANTI-PARASITIC AGENTS
... An indication of drug specificity for target MTNs was gained by examining inhibition profiles against human MTAP, as has been previously reported for transition state analogs of MTA (Longshaw et al., 2010). This ... See full document
90
In silico drug design of potential novel anti malarial agents
... While immunization is an alternative that many groups are working on, the path to designing a single vaccine that can provide long-term immunity against the parasite seems to be fraught with obstacles. Among the various ... See full document
59
Synthesis of heterocyclic chalcones and their novel pyrazoline derivatives
... Hareesh, M., Mahanti, S., Sailu, B., Subramanyam, D., Sakam, S. R., Tara, B., Balram, B., Vasudha, B. and Ram, B. (2012). Synthesis and Antibacterial Evaluation of Some Novel Pyrazoline Derivatives. Der Pharma ... See full document
37
Synthesis and biological evaluation of a novel class of curcumin analogs as anti-inflammatory agents for prevention and treatment of sepsis in mouse model
... of novel AMACs, and evaluated their anti-inflammatory activity both in vitro and in ...the anti-inflammatory activity of 3f might be associated with its inhibition against LPS-induced NF- κ B and ERK ... See full document
16
Anti–PD 1/PD L1 therapy of human cancer: past, present, and future
... However, anti-PD therapy is based on completely different scientific prin- ciples compared with anti–CTLA-4 ...specific anti- gen exposure, and eventually result in death (65, ...of ... See full document
9
Perifosine as a potential novel anti-telomerase therapy
... Most tumors circumvent telomere-length imposed replicative limits through expression of telomerase, the reverse transcriptase that maintains telomere length. Substantial evidence that AKT activity is required for ... See full document
11
Current Cytotoxic Agents and Novel Therapy for Metastasis Nasopharyngeal Cancer
... radiation therapy and chemotherapy experienced complications, including brain injury, trismus, hearing loss or xerostomia and radiation-related cranial nerve ... See full document
17
Andrographolide Analogues: Pharmacophore Modeling and 3D QSAR analysis
... significant anti- tubercular agents crucial for effective therapy against M/XDR TB, by generating 3D pharmacophore and to quantify the structural features of Andrographolide derivatives essential in ... See full document
7
Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials
... dual platelet therapies (using ticagrelor or prasugrel) vs lower intensity dual platelet therapies (using ...dual anti-platelet therapy groups and then subsequently required ... See full document
15
Related subjects